BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $88,000 | +23.9% | 584 | +21.7% | 0.00% | – |
Q2 2022 | $71,000 | -19.3% | 480 | -34.7% | 0.00% | – |
Q1 2022 | $88,000 | -33.8% | 735 | -24.0% | 0.00% | – |
Q4 2021 | $133,000 | +18.8% | 967 | +19.7% | 0.00% | – |
Q3 2021 | $112,000 | +57.7% | 808 | +9.8% | 0.00% | – |
Q2 2021 | $71,000 | +24.6% | 736 | -12.9% | 0.00% | – |
Q1 2021 | $57,000 | -60.4% | 845 | -49.6% | 0.00% | – |
Q4 2020 | $144,000 | +26.3% | 1,676 | -3.7% | 0.00% | – |
Q3 2020 | $114,000 | -8.1% | 1,741 | +1.5% | 0.00% | – |
Q2 2020 | $124,000 | +12300.0% | 1,715 | +6251.9% | 0.00% | – |
Q1 2020 | $1,000 | -75.0% | 27 | -68.6% | 0.00% | – |
Q3 2019 | $4,000 | -20.0% | 86 | -13.1% | 0.00% | – |
Q2 2019 | $5,000 | – | 99 | +280.8% | 0.00% | – |
Q1 2018 | $0 | – | 26 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 26 | +8.3% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 24 | -40.0% | 0.00% | – |
Q2 2017 | $1,000 | – | 40 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |